BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 22350721)

  • 1. 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas.
    Onkendi EO; Boostrom SY; Sarr MG; Farnell MB; Nagorney DM; Donohue JH; Kendrick ML; Reid-Lombardo KM; Harmsen WS; Que FG
    J Gastrointest Surg; 2012 Apr; 16(4):682-91. PubMed ID: 22350721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
    Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
    Tsao JI; Rossi RL; Lowell JA
    Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periampullary adenocarcinoma: analysis of 5-year survivors.
    Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
    Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
    Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct.
    Michelassi F; Erroi F; Dawson PJ; Pietrabissa A; Noda S; Handcock M; Block GE
    Ann Surg; 1989 Oct; 210(4):544-54; discussion 554-6. PubMed ID: 2679459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment of duodenal adenocarcinoma: ampullary vs. non-ampullary, short- and long-term outcomes.
    Tesarikova J; Skalicky P; Kurfurstova D; Svebisova H; Urban O; Falt P; Zapletalova J; Klos D; Lovecek M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Sep; 166(3):290-296. PubMed ID: 34012147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological Stratification and Long-term Follow-up of Patients with Periampullary Carcinomas.
    Schmuck RB; Brokat C; Andreou A; Felsenstein M; Klein F; Sinn B; Pratschke J; Bahra M
    Anticancer Res; 2018 Sep; 38(9):5379-5386. PubMed ID: 30194192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
    Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
    J Surg Oncol; 2007 Mar; 95(4):286-90. PubMed ID: 17326125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Strategy for T1 Duodenal or Ampullary Carcinoma According to the Depth of Tumor Invasion.
    Kohga A; Yamamoto Y; Sano S; Sugiura T; Okamura Y; Ito T; Ashida R; Ishiwatari H; Matsubayashi H; Sasaki K; Uesaka K
    Anticancer Res; 2017 Sep; 37(9):5277-5283. PubMed ID: 28870965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors.
    Untch BR; Bonner KP; Roggin KK; Reidy-Lagunes D; Klimstra DS; Schattner MA; Fong Y; Allen PJ; D'Angelica MI; DeMatteo RP; Jarnagin WR; Kingham TP; Tang LH
    J Gastrointest Surg; 2014 Mar; 18(3):457-62; discussion 462-3. PubMed ID: 24448999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
    Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS
    World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and external validation of a prediction model for survival in patients with resected ampullary adenocarcinoma.
    Moekotte AL; van Roessel S; Malleo G; Rajak R; Ecker BL; Fontana M; Han HS; Rabie M; Roberts KJ; Khalil K; White SA; Robinson S; Halimi A; Zarantonello L; Fusai GK; Gradinariu G; Alseidi A; Bonds M; Dreyer S; Jamieson NB; Mowbray N; Al-Sarireh B; Mavroeidis VK; Soonawalla Z; Napoli N; Boggi U; Kent TS; Fisher WE; Tang CN; Bolm L; House MG; Dillhoff ME; Behrman SW; Nakamura M; Ball CG; Berger AC; Christein JD; Zureikat AH; Salem RR; Vollmer CM; Salvia R; Besselink MG; Abu Hilal M; ; Aljarrah R; Barrows C; Cagigas MN; Lai ECH; Wellner U; Aversa J; Dickson PV; Ohtsuka T; Dixon E; Zheng R; Kowalski S; Freedman-Weiss M
    Eur J Surg Oncol; 2020 Sep; 46(9):1717-1726. PubMed ID: 32624291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
    Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
    Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma.
    Zenali M; Overman MJ; Rashid A; Broaddus RB; Wang H; Katz MH; Fleming JB; Abbruzzese JL; Wang H
    Hum Pathol; 2013 Dec; 44(12):2792-8. PubMed ID: 24139211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting adequate lymph node yield in patients undergoing pancreatoduodenectomy for malignancy.
    Sierzega M; Bobrzyński Ł; Matyja A; Kulig J
    World J Surg Oncol; 2016 Sep; 14(1):248. PubMed ID: 27644962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transduodenal local resection for low-risk group ampulla of vater carcinoma.
    Park JS; Yoon DS; Park YN; Lee WJ; Chi HS; Kim BR
    J Laparoendosc Adv Surg Tech A; 2007 Dec; 17(6):737-42. PubMed ID: 18158802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histopathologic type of the periampullary tumors. Is it important for survival?
    Georgescu SO; Neacşu CN; Vintilă D; Popa P; Florea N; Mihailovici MS
    Chirurgia (Bucur); 2009; 104(6):697-700. PubMed ID: 20187467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
    Schmocker RK; Wright MJ; Ding D; Javed AA; Cameron JL; Lafaro K; Burns WR; He J; Wolfgang CL; Burkhart RA
    J Surg Oncol; 2021 Feb; 123(2):416-424. PubMed ID: 33125737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
    Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
    Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.